Ohr Pharmaceutical Inc 4
4 · Ohr Pharmaceutical Inc · Filed Aug 2, 2016
Insider Transaction Report
Form 4
Slakter Jason Scott
Director
Transactions
- Other
Common Stock, par value $0.0001 per share
2016-07-18+497,859→ 1,195,724 total(indirect: By LLC)
Holdings
- 925,040
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestones 1 and 2 have been met and the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC on each of December 15, 2015 and July 18, 2016. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.